South and Central America Neuromodulation Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Technology (External (Non-Invasive) Neuromodulation, and Internal Neuromodulation); Application (Chronic Pain Management, Failed Back Syndrome, Epilepsy, Tremor, Incontinence, Depression, Dystonia, Gastroparesis, Parkinson’s Disease, Obsessive-Compulsive Disorder, and Migraine); End User (Hospitals, Clinics, and Home Healthcare), and Country

Name: South and Central America Neuromodulation Market
SKU: Medical Device
Rating: 4.9 (15 reviews)

Market Introduction

Neuromodulation is the process of regulating the activity of nerves by controlling the physiological level of neurotransmitters. These modifications are brought about with the help of various devices or by drug infusion. These devices contain small electrodes that are placed on the spinal cord, brain or the peripheral nerves. Neurological disorders such as, cerebrovascular diseases, Alzheimer disease and Parkinson's disease affect the neurological functioning of the body and hence can be treated with the help of neuromodulation.

Market Overview and Dynamics

In the South & Central America, the Neuromodulation market is expected to reach US$ 627.22 million in 2027 from US$ 316.72 million in 2019; the market is estimated to grow at a CAGR of 9.2% from 2020 to 2027. The growth of the market is attributed to the increasing product launches in the market, the rising product innovation for neuromodulation devices and growing developments in neuromodulation technology. However, high cost of neuromodulation devices is likely to restraint the growth of the market during the forecast years.

Key Market Segments

In terms of technology, the External (Non-Invasive) Neuromodulation segment is expected to hold the largest share of the Neuromodulation market by 2027. In terms of application, the Chronic Pain Management held the most significant market share of the Neuromodulation market. In terms of the end user, the hospitals segment is expected to maintain its largest market share by 2027

Major Sources and Companies Listed

Some of the major primary and secondary sources for neuromodulation market included in the report are Mental Health Database, Neurological diseases databases, Alzheimer’s websites, and others.

Reasons to buy the report

To understand the South & Central America Neuromodulation market landscape and identify market segments that are most likely to guarantee a strong return
Stay ahead of the race by comprehending the ever-changing competitive landscape for Neuromodulation market
Efficiently plan M&A and partnership deals in South & Central America Neuromodulation market by identifying market segments with the most promising probable sales
Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form South & Central America Neuromodulation market
Obtain market revenue forecast for market by various segments from 2019 to 2027 in South & Central America region

SOUTH & CENTRAL AMERICA NEUROMODULATION MARKET SEGMENTATION

By Technology

· External (Non-Invasive) Neuromodulation

o Respiratory Electrical Stimulation (RES)

o Transcutaneous Electrical Nerve Stimulation (TENS)

o Transcranial Magnetic Stimulation (TMS)

· Internal Neuromodulation

o Deep Brain Stimulation (DBS)

o Sacral Nerve Stimulation (SNS)

o Gastric Electrical Stimulation (GES)

o Spinal Cord Stimulation (SCS)

o Vagus Nerve Stimulation (VNS)

By Application

· Chronic Pain Management

· Failed Back Syndrome

· Epilepsy

· Tremor

· Incontinence

· Depression

· Dystonia

· Gastroparesis

· Parkinson’s Disease

· Obsessive-Compulsive Disorder

· Migraine

By End User

· Hospitals

· Clinics

By Country

· UAE

· Saudi Arabia

· South Africa

Company Profile-

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Neuromodulation Market – By Technology

1.3.2 Neuromodulation Market – By Application

1.3.3 Neuromodulation Market – By End User

1.3.4 South & Central America Neuromodulation Market – By Country

2. South & Central America Neuromodulation Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. South & Central America Neuromodulation Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 South & Central America– PEST Analysis

4.3 Expert Opinion

5. South & Central America Neuromodulation Market Key Market Dynamics

5.1 Market Drivers

5.1.1 Increasing Incidence of Neurological Disorders

5.1.2 Growing Developments in Neuromodulation Technology

5.2 Market Restraints

5.2.1 High Cost of Neuromodulation Devices

5.3 Market Opportunities

5.3.1 Rising Demand for Neurostimulation Devices to Treat Chronic Pain

5.4 Future Trends

5.4.1 Technological Advancements

5.5 Impact Analysis

6. Neuromodulation Market – South & Central America Analysis

6.1 Neuromodulation Market Revenue Forecasts and Analysis

7. Neuromodulation Market Analysis – By Technology

7.1 Overview

7.2 Neuromodulation Market Share, by Technology, 2019 and 2027 (%)

7.3 External Neuromodulation

7.3.1 Overview

7.3.2 External Neuromodulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

7.3.3 Respiratory Electrical Stimulation (RES)

7.3.3.1 Overview

7.3.3.2 Respiratory Electrical Stimulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

7.3.4 Transcutaneous Electrical Nerve Stimulation (TENS)

7.3.4.1 Overview

7.3.4.2 Transcutaneous Electrical Nerve Stimulation (TENS): Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

7.3.5 Transcranial Magnetic Stimulation (TMS)

7.3.5.1 Overview

7.3.5.2 Transcranial Magnetic Stimulation (TMS): Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

7.4 Internal Neuromodulation

7.4.1 Overview

7.4.2 Internal Neuromodulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

7.4.3 Deep Brain Stimulation (DBS)

7.4.3.1 Overview

7.4.3.2 Deep Brain Stimulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

7.4.4 Sacral Nerve Stimulation (DBS)

7.4.4.1 Overview

7.4.4.2 Sacral Nerve Stimulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

7.4.5 Gastric Electric Stimulation (GES)

7.4.5.1 Overview

7.4.5.2 Gastric Electric Stimulation (GES): Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

7.4.6 Spinal Cord Stimulation (SCS)

7.4.6.1 Overview

7.4.6.2 Spinal Cord Stimulation (SCS): Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

7.4.7 Vagus Nerve Stimulation (VNS)

7.4.7.1 Overview

7.4.7.2 Vagus Nerve Stimulation (VNS): Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

8. Neuromodulation Market Analysis – By Application

8.1 Overview

8.2 Neuromodulation Market Share, by Application, 2019 and 2027 (%)

8.3 Chronic Pain Management

8.3.1 Overview

8.3.2 Chronic Pain Management: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

8.4 Failed Back Syndrome

8.4.1 Overview

8.4.2 Failed Back Syndrome: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

8.5 Epilepsy

8.5.1 Overview

8.5.2 Epilepsy: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

8.6 Tremor

8.6.1 Overview

8.6.2 Tremor: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

8.7 Incontinence

8.7.1 Overview

8.7.2 Incontinence: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

8.8 Depression

8.8.1 Overview

8.8.2 Depression: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

8.9 Dystonia

8.9.1 Overview

8.9.2 Dystonia: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

8.10 Gastroparesis

8.10.1 Overview

8.10.2 Gastroparesis: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

8.11 Parkinson’s Disease

8.11.1 Overview

8.11.2 Parkinson’s Disease: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

8.12 Obsessive-Compulsive Disorder (OCD)

8.12.1 Overview

8.12.2 Obsessive-Compulsive Disorder: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

8.13 Migraine

8.13.1 Overview

8.13.2 Migraine: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

9. Neuromodulation Market Analysis – By End User

9.1 Overview

9.2 Neuromodulation Market Share, by End User, 2019 and 2027, (%)

9.3 Hospitals

9.3.1 Overview

9.3.2 Hospitals: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

9.4 Clinics

9.4.1 Overview

9.4.2 Clinics: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

9.5 Home Healthcare

9.5.1 Overview

9.5.2 Home Healthcare: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

10. Neuromodulation Market – Geographic Analysis

10.1 South & Central America: Neuromodulation Market

10.1.1 Overview

10.1.2 South and Central America: Neuromodulation Market, - Revenue and Forecast to 2027 (USD Million)

10.1.3 South and Central America: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

10.1.3.1 South and Central America: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.1.3.2 South and Central America: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.1.4 South and Central America: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.1.5 South and Central America: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.1.6 South and Central America: Neuromodulation Market, by Country, 2019 & 2027 (%)

10.1.7 Brazil: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

10.1.7.1 Brazil: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

10.1.7.2 Brazil: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

10.1.7.2.1 Brazil: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.1.8 Brazil: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.1.8.1 Brazil: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.1.8.2 Brazil: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.1.9 Argentina: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

10.1.9.1 Argentina: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

10.1.9.2 Argentina: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

10.1.9.2.1 Argentina: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.1.9.2.2 Argentina: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.1.9.3 Argentina: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.1.9.4 Argentina: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

11. Impact of COVID-19 Pandemic on South & Central America Neuromodulation Market

11.1 South & Central America: Impact Assessment of COVID-19 Pandemic

12. Neuromodulation Market – Industry Landscape

12.1 Overview

12.2 Growth Strategies Done by the Companies in the Market, (%)

12.3 Organic Developments

12.3.1 Overview

12.4 Inorganic Developments

12.4.1 Overview

13. Company Profiles

13.1 Abbott

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Boston Scientific Corporation

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 Medtronic

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 NeuroPace, Inc.

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 NeuroSigma, Inc.

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 NEVRO CORP.

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Synapse Biomedical Inc.

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 Soterix Medical Inc

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 Integer Holdings Corporation

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

13.10 Magstim

13.10.1 Key Facts

13.10.2 Business Description

13.10.3 Products and Services

13.10.4 Financial Overview

13.10.5 SWOT Analysis

13.10.6 Key Developments

14. Appendix

14.1 Glossary of Terms

LIST OF TABLES

Table 1. South and Central America: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 2. South and Central America: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 3. South and Central America: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 4. South and Central America: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 5. South and Central America: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 6. Brazil: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 7. Brazil: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 8. Brazil: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 9. Brazil: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 10. Brazil: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 11. Argentina: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 12. Argentina: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 13. Argentina: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 14. Argentina: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 15. Argentina: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 16. Organic Developments Done by Companies

Table 17. Inorganic Developments Done by Companies

Table 18. Glossary of Terms, Neuromodulation Market

LIST OF FIGURES

Figure 1. South & Central America Neuromodulation Market Segmentation

Figure 2. South & Central America Neuromodulation Market, By Country

Figure 3. South & Central America Neuromodulation Market Overview

Figure 4. Internal Neuromodulation Segment Held Largest Share of Technology Segment in South & Central America Neuromodulation Market

Figure 5. Brazil Is Expected to Show Remarkable Growth During the Forecast Period

Figure 6. South & Central America Neuromodulation Market- Leading Country Markets (US$ Mn)

Figure 7. South & Central America PEST Analysis

Figure 8. Neuromodulation Market Impact Analysis of Drivers and Restraint

Figure 9. South & Central America Neuromodulation Market – Revenue Forecasts and Analysis – 2019- 2027

Figure 10. Neuromodulation Market Share, by Technology, 2019 and 2027 (%)

Figure 11. External Neuromodulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

Figure 12. Respiratory Electrical Stimulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

Figure 13. Transcutaneous Electrical Nerve Stimulation (TENS): Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

Figure 14. Transcranial Magnetic Stimulation (TMS): Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

Figure 15. Internal Neuromodulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

Figure 16. Deep Brain Stimulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

Figure 17. Sacral Nerve Stimulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

Figure 18. Gastric Electric Stimulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

Figure 19. Spinal Cord Stimulation (SCS): Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

Figure 20. Vagus Nerve Stimulation (VNS): Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

Figure 21. Neuromodulation Market Share, by Application, 2019 and 2027 (%)

Figure 22. Chronic Pain Management: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

Figure 23. Failed Back Syndrome: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

Figure 24. Epilepsy: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

Figure 25. Tremor: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

Figure 26. Incontinence: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

Figure 27. Depression: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

Figure 28. Dystonia: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

Figure 29. Gastroparesis: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

Figure 30. Parkinson’s Disease: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

Figure 31. Obsessive-Compulsive Disorder: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

Figure 32. Migraine: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

Figure 33. Neuromodulation Market Share, by End User, 2019 and 2027 (%)

Figure 34. Hospitals Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

Figure 35. Clinics: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

Figure 36. Home Healthcare: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

Figure 37. South and Central America: Neuromodulation Market, by Key Country – Revenue (2019) (USD Million)

Figure 38. South and Central America: Neuromodulation Market, Revenue and Forecast to 2027 (USD Million)

Figure 39. South and Central America: Neuromodulation Market, by Country, 2019 & 2027 (%)

Figure 40. Brazil: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

Figure 41. Argentina: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

Figure 42. Impact of COVID-19 Pandemic in South & Central America Country Markets

Figure 43. Growth Strategies Done by the Companies in the Market, (%)

The List of Companies - South & Central America Neuromodulation Market

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the South & Central America Neuromodulation market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the global South & Central America Neuromodulation market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
South America Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software a..	May 2022
South and Central America Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission,..	May 2022
South and Central America In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syring..	May 2022

Purchase Options

Single User License

$3000

$1800

Site License

$4000

$2400

Enterprise License

$5000

$3000

GET FREE SAMPLE PDF

Inquire before Buying Inquire for Discount

Subscription Member Price: FREE

Get Subscription

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

Request for Free Sample